Skip to main content
Brain Pathology logoLink to Brain Pathology
letter
. 2010 Feb 2;20(2):499–502. doi: 10.1111/j.1750-3639.2009.00360.x

A 61‐YEAR‐OLD WOMAN WITH OSTEOMALACIA AND A THORACIC SPINE LESION

Ann E Marshall 1, Sarah E Martin 1, Narasimhan P Agaram 1, Jey‐Hsin Chen 1, Eric M Horn 2, Annette C Douglas‐Akinwande 3, Eyas M Hattab 1
PMCID: PMC8094844  PMID: 20438469

CLINICAL HISTORY AND IMAGING STUDIES

A 55‐year‐old woman presented with bilateral hip and rib pain. A chest radiograph revealed multiple bilateral rib fractures with callus formation. Insufficiency fractures of the right superior and inferior pubic rami and ischium and possibly of the sacrum were noted on hip and pelvic radiographs, and a subsequent MRI showed avascular necrosis of the left femoral head. Laboratory studies demonstrating hypophosphatemia, in combination with the patient's clinical presentation of osteomalacia, prompted further investigation for the underlying cause.

A parathyroid scan, an octreotide body scan, and a whole body sestamibi scan all revealed normal results with no evidence of neoplasm. The patient's diagnosis of avascular necrosis in combination with pain refractory to non‐operative measures resulted in a left total hip arthroplasty.

The patient was lost to follow up until six years later when she presented with bilateral weakness and shooting pains in her legs after a recent fall. She denied back pain and bowel or bladder dysfunction. The work‐up included a full body positron emission tomography/computed tomography (PET/CT), which revealed a 4.3 cm greatest dimension fluoro‐deoxyglucose (FDG18)‐avid expansile lytic lesion involving the left posterior T12 neural arch. At that time the patient's serum fibroblast growth factor‐23 (FGF‐23) level was found to be elevated. Subsequently, an MRI of the spine was performed. Sagittal (Figure 1) and axial (Figure 2) T2‐weighted, unenhanced and axial T1‐weighted, contrast‐enhanced, fat‐suppressed (Figure 3) images revealed a multi‐lobulated, vividly enhancing, heterogeneous mass centered in the left pedicle and laminae of T12, with extension into the epidural space (thick arrows) and posterior paraspinal musculature (thin arrows). The patient underwent T11 to L1 laminectomies and tumor resection.

Figure 1.

Figure 1

Figure 2.

Figure 2

Figure 3.

Figure 3

GROSS AND MICROSCOPIC PATHOLOGY

The gross specimen consisted of multiple fragments of soft tissue and attached bone. The cut surfaces were crunchy and showed areas of focal hemorrhage and cystic degeneration. Histologic examination revealed a fairly well circumscribed, partially encapsulated (Figure 4), moderately cellular tumor with heterogeneous composition (Figure 5). The tumor contained variably sized cystic spaces including large dilated ones filled with blood (Figure 6). The tumor cells appeared spindled with normochromatic, small nuclei and indistinct nucleoli (Figure 7). There was no significant nuclear atypia and mitoses were difficult to find. The tumor cells were focally embedded in a myxochondroid and osteoid‐like matrix (8, 9) with scattered areas of dystrophic calcification (Figure 8). Peripheral foci of ossification were also noted (Figure 10). The tumor was penetrated by capillary‐sized vessels and intermixed with scattered osteoclast‐like giant cells (Figure 11). Bone invasion was focally present.

Figure 4.

Figure 4

Figure 5.

Figure 5

Figure 6.

Figure 6

Figure 7.

Figure 7

Figure 8.

Figure 8

Figure 9.

Figure 9

Figure 10.

Figure 10

Figure 11.

Figure 11

What is your diagnosis?

DIAGNOSIS

Phosphaturic Mesenchymal Tumor, Mixed Connective Tissue Variant (PMT‐MCT)

DISCUSSION

PMT‐MCT is the most common cause of oncogenic osteomalacia 1, 6, 10, 11. PMT‐MCT may not be easily recognized because of its rarity and polymorphic histologic features. Classic histopathologic characteristics include bland spindle cells with small nuclei surrounded by a myxochondroid and osteoid‐like “smudgy” matrix. Other characteristic features include areas of flocculent calcification, osteoclast‐like giant cells, and a well‐developed capillary network (1). Examples that do not show the entire morphologic spectrum of PMT‐MCT are more difficult to recognize. The index case showed classic PMT‐MCT features. In conjunction with an appropriate clinical presentation and laboratory findings, the diagnosis of PMT can often be made on H&E sections; ancillary immunostains with antibodies against FGF‐23 and dentin matrix protein 1 (DMP1) are also helpful in confirming the diagnosis 1, 9.

Patients with PMT‐MCT commonly have a protracted history of bone pain and multiple fractures as well as hypophosphatemia, hyperphosphaturia, elevated alkaline phosphatase activity, and low or inappropriately normal serum 1,25‐dihydroxyvitamin D3 levels. Patients also fail to respond to vitamin D therapy 1, 4, 8. Rarely, osteomalacia may be absent (1). Lesions are often inapparent due to their small size and slow growth. The patient in this case exhibited hypophosphatemic osteomalacia for six years before the tumor was identified despite a thorough work‐up and numerous radiological studies1, 2, 5, 6. Complete surgical resection of the tumor is curative, resulting in resolution of symptoms associated with osteomalacia 1, 2, 4, 8.

PMT‐MCT can originate in the bone or soft tissue of any location, although the extremities or appendicular skeleton account for most cases 1, 6. Reis‐Filho et al reported a case of PMT‐MCT occurring in the cavernous sinus (5). Similar to our case, this patient presented with a protracted history of osteomalacia and hypophosphatemia, and surgical resection was curative. In addition to the morphologic features described in that case, the case described herein displayed a wider morphologic spectrum of PMT‐MCT including the characteristic osteoid‐like matrix, dystrophic calcification, and ossification (5).

Even though PMT‐MCT is a rare tumor and occurs infrequently in the axial skeleton 1, 7, 12, the surgical neuropathologist may occasionally encounter a case like the one described herein. Awareness of the existence of PMT‐MCT as a distinct clinicopathologic entity is crucial for optimal patient outcome since complete surgical resection without additional treatment is curative. Therefore, PMT‐MCT should be added to the differential diagnosis of spinal and paraspinal lesions.

For a more complete discussion please go to: http://path.upmc.edu/divisions/neuropath/bpath/cases/case196/dx.html

Presented, in part, at the 85th annual meeting of the American Association of Neuropathologists, San Antonio, Texas, June 11–13, 2009.

ABSTRACT

Phosphaturic mesenchymal tumor, mixed connective tissue variant (PMT‐MCT) is a rare, largely benign, mesenchymal neoplasm almost invariably associated with oncogenic osteomalacia. It is generally found in the soft tissue and bone of the extremities. We report a case of a 61‐year‐old female with long‐standing osteomalacia who was found to have PMT‐MCT of the thoracic spine. There have been very few previously reported cases of PMT involving the spinal vertebrae and neuropathologists should be aware of this lesion. Recognition of PMT‐MCT is critical for optimal patient care since complete surgical resection without additional therapy is curative.

REFERENCES

  • 1. Folpe AL, Fanburg‐Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, et al (2004) Most osteomalacia‐associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J of Surg Pathol 28(1):1–30. [DOI] [PubMed] [Google Scholar]
  • 2. Koriyama N, Nishimoto K, Kodama T, Nakazaki M, Kurono Y, Yoshida H, Tei C (2006) Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor. Am J Med Sci 332(3):142–7. [DOI] [PubMed] [Google Scholar]
  • 3. Ogura E, Kageyama K, Fukumoto S, Yagihashi N, Fukuda Y, Kikuchi T, Masuda M, Suda T (2008) Development of tumor‐induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor‐23. Intern Med 47(7):637–41. [DOI] [PubMed] [Google Scholar]
  • 4. Policarpio‐Nicolas ML, Abbott TE, Dalkin AC, Bennett‐Wick J, Frierson HF, Jr . (2008) Phosphaturic mesenchymal tumor diagnosed by fine‐needle aspiration and core biopsy: a case report and review of literature. Diagn Cytopathol 36(2):115–9. [DOI] [PubMed] [Google Scholar]
  • 5. Reis‐Filho JS, Paiva ME, Lopes JM (2004) August 2003: 47‐year‐old female with a 7‐year history of osteomalacia and hypophosphatemia. Brain Pathol 14(1):111–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Reyes‐Mugica M, Arnsmeier SL, Backeljauw PF, Persing J, Ellis B, Carpenter TO (2000) Phosphaturic mesenchymal tumor‐induced rickets. Pediatr Dev Pathol 3(1):61–9. [DOI] [PubMed] [Google Scholar]
  • 7. Stone MD, Quincey C, Hosking DJ (1992) A neuroendocrine cause of oncogenic osteomalacia. J Pathol 167(2):181–5. [DOI] [PubMed] [Google Scholar]
  • 8. Sundaram M, McCarthy EF (2000) Oncogenic osteomalacia. Skeletal Radiol 29(3):117–24. [DOI] [PubMed] [Google Scholar]
  • 9. Toyosawa S, Tomita Y, Kishino M, Hashimoto J, Ueda T, Tsujimura T, Aozasa K, Ijuhin N, Komori T (2004) Expression of dentin matrix protein 1 in tumors causing oncogenic osteomalacia. Mod Pathol 17(5):573–8. [DOI] [PubMed] [Google Scholar]
  • 10. Weidner N, Santa Cruz D (1987) Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer 59(8):1442–54. [DOI] [PubMed] [Google Scholar]
  • 11. Yoshioka K, Nagata R, Ueda M, Yamaguchi T, Konishi Y, Hosoi M, Inoue T, Yamanaka K, Iwai Y, Sato T (2006) Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy. Intern Med 45(20):1157–60. [DOI] [PubMed] [Google Scholar]
  • 12. Yu GH, Katz RL, Raymond AK, Gagel RF, Allison A, McCutcheon I (1995) Oncogenous osteomalacia: fine needle aspiration of a neoplasm with a unique endocrinologic presentation. Acta Cytol 39(4):831–2. [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES